Mastopexy Market Report 2025

This Mastopexy market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The mastopexy market size has grown strongly in recent years. It will grow from $2.36 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing social acceptance and normalization of cosmetic procedures, increasing the number of patients undergoing bariatric surgery, adoption of virtual consultations and telemedicine, the increasing establishment of specialized cosmetic surgery, and adoption of patient-centered care models in cosmetic surgery.

The mastopexy market size is expected to see strong growth in the next few years. It will grow to $3.21 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to enhanced pre-operative counseling and post-operative care, growing focus on overall health and self-care motivates, enhanced anesthesia techniques, an aging population, and higher disposable incomes. Major trends in the forecast period include advancements in implant technology, advancements in surgical training and education, regenerative medicine advances, advancements in scar management, and ongoing research and clinical trials.

The growing female geriatric population is expected to drive the expansion of the mastopexy market. This demographic, consisting of women aged 65 and older, is increasing due to longer life expectancies, advancements in healthcare, and declining birth rates in many regions. Mastopexy, or breast lift surgery, is becoming more common among elderly women to enhance breast contour and address age-related changes. For example, data from the World Bank Group indicated that the percentage of females aged 65 and above in the United States rose from 18.1% in 2021 to 19.1% in 2023. This growing female geriatric population is contributing to the market growth for mastopexy.

Key players in the mastopexy market are concentrating on developing advanced products, such as nipple reconstruction solutions, to maintain a competitive edge. These solutions involve surgical techniques and implants designed to recreate the nipple-areola complex for patients who have had mastectomy or breast reconstruction. The goal is to restore the natural appearance and symmetry of the breast. For instance, in March 2024, GC Aesthetics, an Ireland-based medical technology company, launched the FixNip NRI, a nipple implant designed to enhance breast reconstruction. Made from biocompatible silicone and featuring a floral-shaped nitinol frame, this implant aims to improve the aesthetic outcome of breast reconstruction while minimizing incisions and maintaining its shape.

The growing demand for cosmetic procedures is expected to drive the expansion of the mastopexy market in the future. Cosmetic procedures encompass medical treatments or surgeries aimed at enhancing, modifying, or restoring an individual's appearance. The rising demand for these procedures is fueled by factors such as a stronger focus on personal appearance, advances in minimally invasive technologies, and broader societal acceptance of aesthetic enhancements. Mastopexy addresses a common aesthetic concern by restoring the shape, firmness, and position of the breasts, catering to the increasing desire for youthful, firm, and well-contoured appearances, and contributing to the growth of body contouring treatments. For example, in August 2023, The Aesthetic Society, a U.S.-based organization of plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures in total, marking a 2% increase from the previous year. As a result, the rising demand for cosmetic procedures is fueling the growth of the mastopexy market.

Major companies operating in the mastopexy market are AbbVie Inc., Hologic Inc., Spire Healthcare Group plc, Cynosure Inc., Silimed - Industria Ltda Implants, Establishment Labs Holdings Inc., Aurora Clinics, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics, Sebbin SAS, Laboratoires Arion, Polytech Health & Aesthetics GmbH, Ideal Implant Incorporated, Surgiform Technology Ltd, The Esthetic Clinics, Olympus Cosmetic Group, Q Medical Industries, Guangzhou Wanhe Plastic Materials, Rau Plastic Surgery.

North America was the largest region in the mastopexy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mastopexy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mastopexy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mastopexy, commonly referred to as a breast lift, is a surgical procedure designed to raise and reshape sagging breasts. The process involves removing excess skin and tightening the surrounding tissue to create a more youthful breast contour. Mastopexy is often combined with breast augmentation or reduction to achieve the desired volume and shape.

The main types of mastopexy include the Benelli lift (or donut lift), crescent breast lift, lollipop lift, and anchor breast lift. The Benelli lift, also known as the donut lift, involves making a circular incision around the areola (the dark skin surrounding the nipple). The tissue affected includes skin, adipose, and glandular tissue. These procedures are performed in various settings, including hospitals and specialty clinics.

The mastopexy market research report is one of a series of new reports that provides mastopexy market statistics, including mastopexy industry global market size, regional shares, competitors with a mastopexy market share, detailed mastopexy market segments, market trends and opportunities, and any further data you may need to thrive in the mastopexy industry. This mastopexy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mastopexy market consists of revenues earned by entities by providing services such as nipple repositioning, reshaping and lifting, incision techniques, and breast augmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The mastopexy market also includes sales of silicone breast implants, saline breast implants, and composite implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.